A PROSPECTIVE STUDY TO EVALUATE FDG-PET, BREAST MRI, AND BREAST ULTRASONOGRAPHY IN MONITORING TUMOUR RESPONSES IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER (LABC) UNDERGOING NEOADJUVANT CHEMOTHERAPY: